Operating Expenses تغيير تاريخ
Acadia Pharmaceuticals USD 232.19M 7.16M 2025-06
Alnylam Pharmaceuticals USD 789.89M 213.78M 2025-06
Amgen USD 6.52B 337M 2025-06
Biogen USD 1.79B 326.1M 2025-06
BioMarin Pharmaceutical USD 548.52M 27.27M 2025-06
Cytokinetics USD 178.28M 21.06M 2025-06
Daiichi Sankyo JPY 377.89B 57.19B 2025-06
Gilead Sciences USD 4.35B 80M 2025-06
Incyte USD 904.7M 56.97M 2025-06
Ionis Pharmaceuticals USD 312.21M 34.21M 2025-06
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
Novartis USD 9.97B 1.02B 2025-06
Pfizer USD 11.62B 1.58B 2025-06
PTC Therapeutics USD 213.73M 7.86M 2025-06
Roche Holding CHF 11.43B 1.48B 2024-12
Sarepta Therapeutics USD 495.51M 549.73M 2025-06
TG Therapeutics USD 106.3M 5.93M 2025-06
Ultragenyx Pharmaceutical USD 274.38M 7.85M 2025-06
Vertex Pharmaceuticals USD 1.81B 71.4M 2025-06
Xencor USD 76.78M 865K 2025-06


PTC Therapeutics مصروفات التشغيل - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Aug 2025.